79 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
assessment that such internal controls meet the requirements of the Sarbanes-Oxley Act of 2002; provided, however, that Borrower shall be deemed to have made … where such real property is located as to the enforceability of the Mortgage and other customary matters and (vi) an environmental site assessment
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
of the applicable Person and maintained in conformity with GAAP, if required; provided, further, that in the case of a Tax, assessment or charge that has … Collateral to satisfy such Tax, assessment or charge;
(d)(i) pledges or deposits made in the ordinary course of business in connection with workers
8-K
EX-99.2
jabtluenzdo6px
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-2.1
gwr0l0dcnc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
e241exdexqd
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B3
mdbrn
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
53ul6gcpb5 kb
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
v2jyi9wyh qeu
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
119yoim5zt766 wl390m
16 Jun 23
Business combination disclosure
5:12pm
425
tft 8nensng
16 Jun 23
Business combination disclosure
8:08am
425
sy1 1aldelg7
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
upk2l 6k3i4qe
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
5q1vta eyb00
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am